secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K/A
Filed at:   2021-08-24T23:59:59+00:00
Accession:  0000105770-21-000076
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharma corrects prior 8-K: Molly Joseph was CEO of UnitedHealthcare Global, not UnitedHealthcare Group
--------------------------------------------------------------------------------

- Molly Joseph elected to Board on Aug 19, 2021; board size increased to 11.
- Corrected title: former CEO of UnitedHealthcare Global and EVP of UnitedHealth Group.
- Expected to serve on Finance and Innovation & Technology Committees.
- Compensation: $90k annual retainer plus $190k RSU grant, prorated for service.
- Joseph also serves on First Solar board and Santa Clara University trustees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577021000076/0000105770-21-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577021000076/wst-20210819.htm
  HTML page:      https://secwatch.observer/filing/0000105770-21-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer